Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleophosmin 1 pseudogene 6 (NPM1P6)
- Target
- NPM1P6
- Molecular classification
- Other (Pseudogene)
01
Overview
Nucleophosmin 1 pseudogene 6 (NPM1P6) is a non-coding, intronless pseudogene in humans[1][3]. It shares sequence similarity with the NPM1 gene, which encodes the nucleolar protein nucleophosmin (B23, numatrin), but NPM1P6 itself does not produce a functional protein and has no demonstrated biological activity or clinical relevance. Unlike the functional NPM1 gene, which is involved in vital processes such as ribosome assembly, genomic stability, and is implicated in cancer biology, NPM1P6 is not considered a receptor, enzyme, transcription factor, or therapeutic target and is not associated with disease mechanisms or drug activity[7][1][3].
- Other names
- NG6-4NPMP6
Beyond the preview
Go deeper on Nucleophosmin 1 pseudogene 6 (NPM1P6).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nucleophosmin 1 pseudogene 6 (NPM1P6).